✦ LIBER ✦

PCV33 A COST-EFFECTIVENESS ANALYSIS OF LOW-DOSE ASPIRIN IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN FOUR EUROPEAN COUNTRIES

✍ Scribed by M Lamotte; L Annemans; T Evers; M Kubin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized Trial of Low-Dose Aspirin i

✍ P.M. Ridker; N.R. Cook; I.M. Lee 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 32 KB

PCV93 the Polypill in the Primary Preven

✍ P.F. Van Gils; H.H. Hamberg-van Reenen; E. Over; G.A. de Wit; M. van den Berg; A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PCV111 A PATIENT'S VIEW OF THE COST-EFFE

✍ M Amirsadri-Naeini; PR Jackson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

PCV9: COMPARISON OF THE EPIDEMIOLOGY AND

✍ V Munro; J Hutton; O Mast; P Sagnier 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

PCV69 Economic Evaluation of Primary Pre

✍ J. Stevanovic; A.C. O'Prinsen; M.J. Postma; P. Pechlivanoglou 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Cost-Effectiveness Model of Use of Genet

✍ Dov Shiffman; Katherine Slawsky; Lauren Fusfeld; James J. Devlin; Thomas F. Goss 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 355 KB